- Home
- Mutual Funds
- AMC
- Nippon India Mutual Fund
- Nippon India Pharma Fund Idcw Direct Plan
Nippon India Pharma Fund Idcw Direct Plan
NAV (Nov 29,2023)
Nippon India Pharma Fund Idcw Direct Plan Latest Trend
- 1M
- 2M
- 3M
Nippon India Pharma Fund Idcw Direct Plan Latest Trend
Risk Ratios
- P/E Ratio45.00
- P/B Ratio6.34
- Alpha0.02
- Beta0.92
- Sharpe0.14
- Sortino0.28
Fund Overview
0.97%
0%
No Lock-in
₹ 5539.19 Cr
SIP ₹5000.00
Scheme Riskometer
Investors understand that their principal will be at
Very High
Investment Return Calculator
as on Dec 01, 2023
Total Invested Amount | 3 Months Absolute Return (In %) | 6 Months Absolute Return (In %) | 1 Year Absolute Return (In %) | 3 Year Absolute Return (In %) | 5 Year Absolute Return (In %) |
|---|---|---|---|---|---|
| ₹ 10,000 | ₹ 10,770.61 (7.71%) | ₹ 13,013.86 (30.14%) | ₹ 12,931.72 (29.32%) | ₹ 16,132.91 (61.33%) | ₹ 25,441.89 (154.42%) |
| ₹ 30,000 | ₹ 32,311.83 (7.71%) | ₹ 39,041.58 (30.14%) | ₹ 38,795.16 (29.32%) | ₹ 48,398.73 (61.33%) | ₹ 76,325.67 (154.42%) |
| ₹ 50,000 | ₹ 53,853.05 (7.71%) | ₹ 65,069.3 (30.14%) | ₹ 64,658.6 (29.32%) | ₹ 80,664.55 (61.33%) | ₹ 1,27,209.45 (154.42%) |
| ₹ 80,000 | ₹ 86,164.88 (7.71%) | ₹ 1,04,110.88 (30.14%) | ₹ 1,03,453.76 (29.32%) | ₹ 1,29,063.28 (61.33%) | ₹ 2,03,535.12 (154.42%) |
| ₹ 1,00,000 | ₹ 1,07,706.1 (7.71%) | ₹ 1,30,138.6 (30.14%) | ₹ 1,29,317.2 (29.32%) | ₹ 1,61,329.1 (61.33%) | ₹ 2,54,418.9 (154.42%) |
Calculate Your Mutual Fund Returns
Fund Portfolio Allocation
- Holdings
- Sectors
Name
Assets
- Sun Pharmaceutical Industries Limited12.88%
- Lupin Limited7.75%
- Cipla Limited6.50%
- Dr Reddy s Laboratories Limited5.33%
- Apollo Hospitals Enterprise Limited4.47%
- MedPlus Health Services Limited4.40%
- Divi s Laboratories Limited4.29%
- Gland Pharma Limited4.19%
- Triparty Repo4.04%
- Aurobindo Pharma Limited3.83%
- JB Chemicals & Pharmaceuticals Limited3.78%
- Vijaya Diagnostic Centre Limited3.49%
- Narayana Hrudayalaya Limited3.42%
- Zydus Lifesciences Limited3.31%
- Sanofi India Limited3.22%
- Abbott India Limited3.09%
- Mankind Pharma Limited3.08%
- Ajanta Pharma Limited3.08%
- Alkem Laboratories Limited2.70%
- Torrent Pharmaceuticals Limited2.10%
- Pfizer Limited2.08%
- Fortis Healthcare Limited2.04%
- Thyrocare Technologies Limited1.75%
- Indoco Remedies Limited1.05%
- Concord Biotech Limited1.04%
- Syngene International Limited0.86%
- Orchid Pharma Limited0.85%
- GlaxoSmithKline Pharmaceuticals Limited0.67%
- Jubilant Pharmova Limited0.37%
- Healthcare Global Enterprises Limited0.27%
- Tarsons Products Limited0.19%
- Cash Margin CCIL0.02%
- Net Current Assets-0.15%
- Pharmaceuticals & Drugs79.59%
- Miscellaneous3.92%
- Plastic Products0.19%
Holdings Analysis
Peer Comparison
Pick your choice with our quick comparitive analysis
- 6M
- 1Y
- 3Y
- 5Y
| Mutual Fund Schemes | Category | Risk | Absolute Return (6M) |
| EQUITY | Very High | 36.45% |
| EQUITY | Very High | 27.72% |
| EQUITY | Very High | 25.80% |
| EQUITY | Very High | 24.90% |
| EQUITY | Very High | 23.74% |
| EQUITY | Very High | 21.99% |
| EQUITY | Very High | 20.74% |
| EQUITY | Very High | 19.43% |
| EQUITY | Very High | 15.00% |
| EQUITY | Very High | 14.33% |
HDFC Infrastructure Fund - Growth
Bank of India Manufacturing & Infrastructure Fund - Regular Plan - Growth
DSP India T.I.G.E.R. Fund - Regular Plan - Growth
Invesco India Infrastructure Fund - Growth
Quant Infrastructure Fund - Growth
Tata Infrastructure Fund - Regular Plan - Growth
Sundaram Infrastructure Advantage Fund - Growth
UTI Transportation and Logistics Fund - Regular Plan - IDCW
Kotak Infrastructure and Economic Reform Fund - Growth
Mahindra Manulife Consumption Fund - Regular Plan - Growth| Mutual Fund Schemes | Category | Risk | Absolute Return (6Y) |
| EQUITY | Very High | 40.04% |
| EQUITY | Very High | 35.52% |
| EQUITY | Very High | 34.55% |
| EQUITY | Very High | 29.86% |
| EQUITY | Very High | 29.68% |
| EQUITY | Very High | 25.04% |
| EQUITY | Very High | 24.73% |
| EQUITY | Very High | 22.84% |
| EQUITY | Very High | 18.28% |
| EQUITY | Very High | 18.16% |
Bandhan Infrastructure Fund - Regular Plan - Growth
LIC MF Infrastructure Fund - Regular Plan - Growth
Mirae Asset Great Consumer Fund - Regular Plan - Growth| Mutual Fund Schemes | Category | Risk | Absolute Return (6Y) |
| EQUITY | Very High | 33.72% |
| EQUITY | Very High | 31.83% |
| EQUITY | Very High | 29.80% |
| EQUITY | Very High | 26.28% |
| EQUITY | Very High | 21.28% |
| EQUITY | Very High | 21.26% |
| EQUITY | Very High | 19.97% |
| EQUITY | Very High | 18.05% |
| EQUITY | Very High | 13.52% |
| DEBT | Low | 9.43% |
SBI Infrastructure Fund - Regular Plan - Growth
Canara Robeco Infrastructure Fund - Regular Plan - Growth
Taurus Infrastructure Fund - Regular Plan - Growth
ICICI Prudential FMCG Fund - Growth
IDBI Banking & Financial Services Fund - Regular Plan - Growth
Aditya Birla Sun Life India GenNext Fund - Growth
Franklin India Technology Fund - Growth
Baroda BNP Paribas Banking and Financial Services Fund - Regular Plan - Growth
IL&FS Infrastructure Debt Fund - Series 1-C - Regular Plan - Growth| Mutual Fund Schemes | Category | Risk | Absolute Return (6Y) |
| EQUITY | Very High | 28.23% |
| EQUITY | Very High | 22.92% |
| EQUITY | Very High | 22.20% |
| EQUITY | Very High | 20.97% |
| EQUITY | Very High | 20.83% |
| EQUITY | Very High | 19.24% |
| EQUITY | Very High | 17.29% |
| EQUITY | Very High | 16.58% |
| EQUITY | Very High | 12.29% |
| EQUITY | Very High | 8.63% |
Get your latest Credit Score, FREE
Most Trusted AMC
- Baroda BNP Paribas Mutual Fund
- Aditya Birla Sun Life Mutual Fund
- Canara Robeco Mutual Fund
- L&T Mutual Fund
- DSP Mutual Fund
- Quant Mutual Fund
- Franklin Templeton Mutual Fund
- HDFC Mutual Fund
- HSBC Mutual Fund
- ICICI Prudential Mutual Fund
- JM Financial Mutual Fund
- Kotak Mahindra Mutual Fund
- LIC Mutual Fund
- Invesco Mutual Fund
- Quantum Mutual Fund
- SBI Mutual Fund
- Bandhan Mutual Fund
- Sundaram Mutual Fund
- Tata Mutual Fund
- Taurus Mutual Fund
- UTI Mutual Fund
- Mirae Asset Mutual Fund
- Bank of India Mutual Fund
- Edelweiss Mutual Fund
- Axis Mutual Fund
- Navi Mutual Fund
- Motilal Oswal Mutual Fund
- IDBI Mutual Fund
- PGIM India Mutual Fund
- Union Mutual Fund
- 360 ONE Mutual Fund
- Groww Mutual Fund
- PPFAS Mutual Fund
- IL&FS Mutual Fund (IDF)
- Shriram Mutual Fund
- IIFCL Mutual Fund
- Mahindra Manulife Mutual Fund
- WhiteOak Capital Mutual Fund
- ITI Mutual Fund
- Trust Mutual Fund
- NJ Mutual Fund
- Samco Mutual Fund
- Bajaj Finserv Mutual Fund
- Helios Mutual Fund
- Zerodha Mutual Fund
Best equity Mutual Funds
- SBI Small Cap Fund - IDCW - Direct Plan
- Axis Small Cap Fund - Growth - Direct Plan
- HDFC Mid-Cap Opportunities Fund - Growth - Direct Plan
- UTI Mid Cap Fund - IDCW - Direct Plan
- ICICI Prudential Smallcap Fund - IDCW - Direct Plan
- Tata Small Cap Fund - Growth - Direct Plan
- Canara Robeco Infrastructure Fund - Growth - Direct Plan
- DSP Small Cap Fund - Growth - Direct Plan
- Mirae Asset Healthcare Fund - Growth - Direct Plan
- Sundaram Small Cap Fund - Growth - Direct Plan (Adjusted)
- Franklin India Smaller Companies Fund - Growth - Direct Plan
- L&T India Large Cap Fund - Growth - Direct Plan
- Motilal Oswal Midcap Fund - Growth - Direct Plan
Compare with similar Funds
Nippon India Pharma Fund - IDCW - Direct Plan
Nippon India Pharma Fund - IDCW - Direct Plan
Nippon India Pharma Fund - IDCW - Direct Plan
Nippon India Pharma Fund - IDCW - Direct Plan
Nippon India Pharma Fund - IDCW - Direct Plan
Nippon India Pharma Fund - IDCW - Direct Plan
